(Q34746170)

4 August 2017

1 reference

title

Primary biliary cirrhosis and other ductopenic diseases (English)

1 reference

primary biliary cholangitis

4 August 2017

main subject

0 references

author name string

Alastair D Burt

series ordinal

1

1 reference

4 August 2017

publication date

1 May 2002

1 reference

4 August 2017

published in

Clinics in liver disease

1 reference

4 August 2017

volume

6

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

363-80, vi

1 reference

The normal adult human liver biopsy: a quantitative reference standard

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

The canals of Hering and hepatic stem cells in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Bile duct proliferation--its true significance?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Does primary biliary cirrhosis in men differ from primary biliary cirrhosis in women?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Presentation and mortality of primary biliary cirrhosis in older patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Primary biliary cirrhosis once rare, now common in the United Kingdom?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Epidemiology of primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Features of Sjögren's syndrome in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Immunohistochemical localization of antigen presenting cells in liver from patients with primary biliary cirrhosis; highly restricted distribution of CD83-positive activated dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Quantitation of hepatic granulomas and epithelioid cells in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Sarcoidosis of the liver and bile ducts

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Pathology of septum formation in primary biliary cirrhosis: A histological study in the non-cirrhotic stage

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Recurrent primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Blood fetal microchimerism in primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Primary biliary cirrhosis: clinical and associated autoimmune features and natural history

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Primary biliary cirrhosis: an orchestrated immune response against epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Three-dimensional structure of the major autoantigen in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Membrane dihydrolipoamide acetyltransferase (E2) on human biliary epithelial cells in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Helicobacters and biliary tract disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Are infectious agents involved in primary biliary cirrhosis? A PCR approach

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis: is Propionibacterium acnes involved in granuloma formation?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

[A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)]

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Small-duct primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Sclerosing cholangitis in the paediatric patient

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

A case of longstanding primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Natural history and prognostic variables in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

The spectrum of bile duct lesions in end-stage primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Serum levels of interleukins 8 and 10, interferon gamma, granulocyte-macrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Serum autoantibodies in patients with primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Association of primary sclerosing cholangitis with HLA-DRw52a

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Etiology and natural history of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

A survey of cytomegalovirus (CMV) DNA in primary sclerosing cholangitis (PSC) liver tissues using a sensitive polymerase chain reaction (PCR) based assay

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Sclerosing cholangitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Idiopathic adulthood ductopenia: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Idiopathic biliary ductopenia in adults without symptoms of liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Familial idiopathic adulthood ductopenia: a report of five cases in three generations

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Nonsyndromic paucity of intrahepatic bile ducts in infancy and idiopathic ductopenia in adulthood: the same syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Vanishing bile duct syndrome in drug-induced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2802%2900010-7

7 January 2021

10.1016/S1089-3261(02)00010-7

Identifiers

DOI

1 reference

4 August 2017

1 reference